Our Partnering Strategy
Aurigene aims to be a commercial stage company with a focus on India, certain Asian markets and other geographies over the next few years. Towards this end Aurigene has started to clinically develop its programs with a focus on India, where clinical needs and a large patient population afford a unique opportunity in terms of speed of development and economics. At the same time, our pipeline remains globally relevant and competitive, providing development and commercialization opportunities for our partners.
Resources required to meet Aurigene’s objective would be met through an appropriate monetization strategy of its pipeline.
- Lead stage programs are available for global licensing
- Candidate and clinical stage programs are proposed to be licensed ex-Asia and territories of Aurigene’s interest. In such programs, Aurigene intends to continue clinical development in India and share data with its partners to enable rapid global development.
Aurigene has the flexibility to create appropriate licensing structures with biotechs and/ or Pharma partners, as corroborated by its existing relationships.